30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
MEF2D, ZNF384 and DUX4 are new fusion genotypes newly identified in “B-others ALL”.
EP300/ZNF384 fusion is one of these subtypes, which is associated with poor prognosis, but has a better prognosis than ZNF384/TCF3. Clinically, ZNF384 can be tested first and if it is positive, then further differentiation between EP300/ZNF384 or ZNF384/TCF3 can be considered.